Correlation Between HOME DEPOT and Rakovina Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HOME DEPOT and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HOME DEPOT and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HOME DEPOT CDR and Rakovina Therapeutics, you can compare the effects of market volatilities on HOME DEPOT and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HOME DEPOT with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HOME DEPOT and Rakovina Therapeutics.

Diversification Opportunities for HOME DEPOT and Rakovina Therapeutics

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between HOME and Rakovina is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding HOME DEPOT CDR and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and HOME DEPOT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HOME DEPOT CDR are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of HOME DEPOT i.e., HOME DEPOT and Rakovina Therapeutics go up and down completely randomly.

Pair Corralation between HOME DEPOT and Rakovina Therapeutics

Assuming the 90 days trading horizon HOME DEPOT CDR is expected to generate 0.18 times more return on investment than Rakovina Therapeutics. However, HOME DEPOT CDR is 5.47 times less risky than Rakovina Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Rakovina Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  2,511  in HOME DEPOT CDR on December 20, 2024 and sell it today you would lose (233.00) from holding HOME DEPOT CDR or give up 9.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.36%
ValuesDaily Returns

HOME DEPOT CDR  vs.  Rakovina Therapeutics

 Performance 
       Timeline  
HOME DEPOT CDR 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days HOME DEPOT CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Rakovina Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Rakovina Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

HOME DEPOT and Rakovina Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HOME DEPOT and Rakovina Therapeutics

The main advantage of trading using opposite HOME DEPOT and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HOME DEPOT position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.
The idea behind HOME DEPOT CDR and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals